Correlation Between Immunic and Pmv Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Immunic and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunic and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunic and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Immunic and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunic with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunic and Pmv Pharmaceuticals.
Diversification Opportunities for Immunic and Pmv Pharmaceuticals
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Immunic and Pmv is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Immunic and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Immunic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunic are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Immunic i.e., Immunic and Pmv Pharmaceuticals go up and down completely randomly.
Pair Corralation between Immunic and Pmv Pharmaceuticals
Given the investment horizon of 90 days Immunic is expected to under-perform the Pmv Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Immunic is 1.15 times less risky than Pmv Pharmaceuticals. The stock trades about -0.06 of its potential returns per unit of risk. The Pmv Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 142.00 in Pmv Pharmaceuticals on August 27, 2025 and sell it today you would lose (10.00) from holding Pmv Pharmaceuticals or give up 7.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 98.44% |
| Values | Daily Returns |
Immunic vs. Pmv Pharmaceuticals
Performance |
| Timeline |
| Immunic |
| Pmv Pharmaceuticals |
Immunic and Pmv Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immunic and Pmv Pharmaceuticals
The main advantage of trading using opposite Immunic and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunic position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.| Immunic vs. World Houseware Limited | Immunic vs. Urban Outfitters | Immunic vs. Triumph Apparel | Immunic vs. PDS Biotechnology Corp |
| Pmv Pharmaceuticals vs. Prologic Management Systems | Pmv Pharmaceuticals vs. Space Communication | Pmv Pharmaceuticals vs. CTPartners Executive Search | Pmv Pharmaceuticals vs. On4 Communications |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |